ROME, ITALY — Using the factor Xa inhibitor edoxaban (Savaysa/Lixiana, Daiichi Sankyo) to anticoagulate patients about to undergo electrical cardioversion for their atrial fibrillation (AF) seems ...
A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...
All the selected patients for the study were under antiarrhythmic drug treatment (amiodarone 200 mg/day) before the procedure and during the whole follow-up after ECV. Moreover, all of them were also ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback